Promoting Rational Therapeutics: the Swedish Guidelines and a UK Response
Overview
Authors
Affiliations
Smith A, Tasioulas T, Cockayne N, Misan G, Walker G, Quick G Br J Clin Pharmacol. 2006; 62(6):653-9.
PMID: 17118123 PMC: 1885196. DOI: 10.1111/j.1365-2125.2006.02651.x.
A review of limited lists and formularies: are they cost-effective?.
Pearce M, Begg E Pharmacoeconomics. 1992; 1(3):191-202.
PMID: 10147029 DOI: 10.2165/00019053-199201030-00006.
Rational prescribing in primary care--a new role for clinical pharmacology?.
Walley T Br J Clin Pharmacol. 1993; 36(1):11-2.
PMID: 8373707 PMC: 1364547. DOI: 10.1111/j.1365-2125.1993.tb05884.x.
Reflections on a month in the life of the Ontario Drug Benefit Plan.
McIsaac W, Naylor C, Anderson G, OBrien B CMAJ. 1994; 150(4):473-7.
PMID: 8313259 PMC: 1486283.